Pacific Edge Reaches Deal with America's Choice Provider Network | GenomeWeb

NEW YORK (GenomeWeb News) – Pacific Edge today announced it has signed on payor America's Choice Provider Network, expanding access to its bladder cancer test.

ACPN's clients include contracted insurance carriers, third-party administrators, health and welfare funds, employer groups, and self-insured health plans. According to Pacific Edge, 14 million patients in ACPN's network now will have access to its Cxbladder test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.